TruNorth Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

TruNorth Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45	Closed	-$21.8K	–	351
2025 Q3	$21.8K	Buy	45 +33	+275%	+$15.4K	﹤0.01%	281
2025 Q2	$4.87K	Hold	12	–	–	﹤0.01%	311
2025 Q1	$5.97K	Hold	12	–	–	﹤0.01%	388
2024 Q4	$6.24K	Sell	12 -14	-54%	-$7.7K	﹤0.01%	309
2024 Q3	$16.1K	Buy	26 +6	+30%	+$3.55K	﹤0.01%	248
2024 Q2	$11.1K	Sell	20 -31	-61%	-$17.8K	﹤0.01%	245
2024 Q1	$29.6K	Buy	+51	New	+$28.6K	0.01%	132

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TruNorth Capital Management's TMO Position: Q4 2025 in Review

TruNorth Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 45 shares — an estimated $21.8K sold.

TruNorth Capital Management first reported a position in TMO in Q1 2024 and held it in 7 quarters. The position peaked at $29.6K in Q1 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

TruNorth Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
TruNorth Capital Management sold 45 Thermo Fisher Scientific shares in Q4 2025, an estimated $21.8K.
TruNorth Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 7 quarters.
TruNorth Capital Management's Thermo Fisher Scientific position peaked at $29.6K in Q1 2024.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.